Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior

November 26, 2025 updated by: University Ghent

People in detention are at significantly higher risk of suicide compared to the general population. In Belgian prisons, the suicide rate is five times higher than average. Despite the availability of suicide prevention tools, many are not scientifically validated or adapted to the detention context, leading to inconsistent use and missed warning signs.

This study aims to evaluate and adapt three evidence-based suicide prevention tools-the Safety Plan, the guideline for the care and evaluation of suicidality , and the Risk Formulation template-for use in detention settings. Through interviews with both professionals working in prisons and individuals in detention, the study explores how these tools can be made more relevant, practical, and effective in this unique environment.

The research involves 40 participants: 20 professionals and 20 individuals in detention. Interviews will gather feedback on the tools' usability, clarity, and fit with the realities of prison life. The ultimate goal is to improve suicide prevention practices in detention by offering tailored, scientifically grounded tools that support both staff and detainees.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Belgium
    • East-Flanders
      • Ghent, East-Flanders, Belgium, 9000
        • Recruiting
        • Flemish Centre of Expertise in Suicide Prevention, Ghent University
        • Contact:
        • Sub-Investigator:
          • Eva De Jaegere, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Participants will be drawn from Belgian detention facilities and the prison-based care network. Specifically:

  • Professionals working in detention: Psychologists, psychiatrists, social workers, nurses, and other healthcare staff working within Belgian detention centers who have had experience in suicide prevention.
  • People in detention: Adults held in selected Belgian prisons who are clinically stable and able to participate in a one-hour interview. Referrals will be made by prison psychologists, social workers, or healthcare staff.

Description

For professionals working in detention:

Inclusion criteria:

  • Aged 18 years or older
  • Currently working in a professional care role within a prison setting (e.g., psychologist, psychiatirst, social worker, nurse, etc.)
  • Experience in supporting or treating incarcerated individuals with suicidal thoughts or behaviours

Exclusion Criteria:

  • Under the age of 18
  • Not employed in a professional caregiving role within detention (e.g., correctional officers or security staff)

For people in detention:

Inclusion criteria:

  • Aged 18 years or older
  • Experienced suicidal thoughts within the past three years

Exclusion criteria:

  • Under the age of 18
  • Significant cognitive limitations that would make the participation in an interview infeasible
  • Insufficient command of the Dutch language to understand and respond to interview questions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Individuals in detention
Participants are individuals in detention which is invited to participate in semi-structured interviews. If they agree, their referrer will schedule a date for the interview at the prison with the researcher.
Other: Co-creation process for suicide prevention tools in detention

The intervention consists of a co-creation process involving detained individuals and detention professionals through semi-structured interviews.

For professionals, the interviews will focus on the usability, applicability, and implementation of three suicide prevention tools.

Interviews with individuals in detention will focus only on the Safety Plan. They will be asked about what helps them in moments of crisis and their views on the Safety Plan in detention.

The goal is to collect feedback on usability, perceived barriers, and suggestions for real-world implementation in the detention context. Interviews are repeated up to three times per professional participants depending on availability and co-creation progress. For individuals in detention there is only one interview. Feedback from all participants will be used to adapt and refine the tools for future use in detention facilities.
Professionals working in detention
Participants are professionals working in detention settings, such as psychologists, psychiatrists, social workers, and nurses. They are invited to participate in semi-structured interviews. If they agree, the researcher will contact them to schedule a date for the interview at the prison.
Other: Co-creation process for suicide prevention tools in detention

The intervention consists of a co-creation process involving detained individuals and detention professionals through semi-structured interviews.

For professionals, the interviews will focus on the usability, applicability, and implementation of three suicide prevention tools.

Interviews with individuals in detention will focus only on the Safety Plan. They will be asked about what helps them in moments of crisis and their views on the Safety Plan in detention.

The goal is to collect feedback on usability, perceived barriers, and suggestions for real-world implementation in the detention context. Interviews are repeated up to three times per professional participants depending on availability and co-creation progress. For individuals in detention there is only one interview. Feedback from all participants will be used to adapt and refine the tools for future use in detention facilities.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Evaluation of Suicide Prevention Tools in the Detention Context
Time Frame: Each participant is assessed during one (for incarcerated individuals) or up to three (for professionals) interviews
This outcome measure assesses the usability, applicability, and improvement potential of three suicide prevention tools based on qualitative feedback from professionals working in detention and individuals in detention. Through semi-structured interviews, the study explores how these tools are experienced in practice, identifies perceived strengths and limitations, and gathers concrete suggestions for adaptation to better fit the detention environment.
Each participant is assessed during one (for incarcerated individuals) or up to three (for professionals) interviews

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University Ghent

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Gwendolyn Portzky, PhD, Flemish Centre of Expertise in Suicide Prevention (Ghent University)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 27, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 12, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 26, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 2, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 2, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 26, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • ONZ-2025-0349

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidal Ideation

Clinical Trials on Co-creation process for suicide prevention tools in detention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings